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ABSTRACT 26 
Purpose: To define the effect of glucose ingestion compared to sucrose 27 
ingestion on liver and muscle glycogen depletion during prolonged 28 
endurance-type exercise. Methods: Fourteen cyclists completed two 3-h 29 
bouts of cycling at 50% of peak power output while ingesting either glucose or 30 
sucrose at a rate of 1.7 g/min (102 g/h). Four cyclists performed an additional 31 
third test in which only water was consumed for reference. We employed 13C 32 
magnetic resonance spectroscopy to determine liver and muscle glycogen 33 
concentrations before and after exercise. Expired breath was sampled during 34 
exercise to estimate whole-body substrate use. Results: Following glucose 35 
and sucrose ingestion, liver glycogen levels did not show a significant decline 36 
following exercise (from 325±168 to 345±205 and 321±177 to 348±170 37 
mmol/L, respectively; P>0.05) with no differences between treatments. Muscle 38 
glycogen concentrations declined (from 101±49 to 60±34 and 114±48 to 39 
67±34 mmol/L, respectively; P<0.05), with no differences between treatments. 40 
Whole-body carbohydrate utilization was greater with sucrose (2.03±0.43 41 
g/min) vs glucose ingestion (1.66±0.36 g/min; P<0.05). Both liver (from 42 
454±33 to 283±82 mmol/L; P<0.05) and muscle (from 111±46 to 67±31 43 
mmol/L; P<0.01) glycogen concentrations declined during exercise when only 44 
water was ingested. Conclusion: Both glucose and sucrose ingestion prevent 45 
liver glycogen depletion during prolonged endurance-type exercise. Sucrose 46 
ingestion does not preserve liver glycogen concentrations more than glucose 47 
ingestion. However, sucrose ingestion does increase whole-body 48 
carbohydrate utilization compared to glucose ingestion. This trial was 49 
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registered at clinicaltrials.gov as NCT02110836. Keywords: glucose; hepatic; 50 
metabolism; nutrition; sucrose   51 
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Introduction 52 
Carbohydrate and fat are the main substrates oxidized during moderate-53 
intensity, endurance-type exercise (41). In the fasted state, muscle glycogen 54 
and plasma glucose are predominant sources of carbohydrate for oxidation 55 
(41), the latter continuously replenished by glycogenolysis and 56 
gluconeogenesis from the liver, with smaller contributions from the kidneys 57 
and intestine (30). Consequently, in the absence of carbohydrate 58 
consumption, liver and muscle glycogen concentrations decrease by 40-60% 59 
within 90 min of exercise at a workload of 70% of peak oxygen uptake 60 
( V̇O2 peak) (6, 37). Given the importance of liver glycogen for metabolic 61 
regulation (16), and the close relationship between liver glycogen content and 62 
exercise tolerance (6), it is important to understand the impact of 63 
carbohydrate ingestion on liver glycogen depletion during exercise. 64 
Carbohydrate feeding during prolonged (>2 h) moderate-to-high intensity, 65 
endurance-type exercise enhances endurance performance and capacity 66 
(42), attributed to the facilitation of high rates of carbohydrate oxidation, 67 
prevention of hypoglycaemia and (under certain conditions) sparing of muscle 68 
glycogen (7, 38). Though some support has been provided that carbohydrate 69 
ingestion can attenuate muscle glycogen depletion (36, 39, 40), others have 70 
failed to confirm these findings (8, 12, 15, 20). Furthermore, prevention of liver 71 
glycogen depletion has been suggested (3, 20, 21), but this has never been 72 
experimentally assessed. We speculate that carbohydrate ingestion during 73 
exercise attenuates the decline in both liver as well as skeletal muscle 74 
glycogen contents. 75 
 76 
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To maximize carbohydrate availability during exercise, carbohydrate digestion 77 
and absorption should be optimized. Previous work suggests that exogenous 78 
glucose uptake by the gastrointestinal tract during exercise is restricted to ~1 79 
g/min (5, 17, 19), attributed to saturation of the sodium-glucose luminal 80 
transporter-1 (SGLT-1). However, combined ingestion of glucose and fructose 81 
at ≥1.8 g/min has been shown to result in much higher exogenous 82 
carbohydrate oxidation rates (up to 1.75 g/min), compared to the ingestion of 83 
equal amount of glucose alone (17, 19). The greater uptake and oxidative 84 
capacity of glucose and fructose mixtures has been attributed to fructose 85 
being absorbed by the glucose transporter-5 (GLUT-5) in the intestine (11). 86 
As sucrose (commonly referred to as table sugar) combines glucose and 87 
fructose monomers, and sucrose hydrolysis is not rate limiting for intestinal 88 
absorption (14, 43), we hypothesize that sucrose ingestion at a rate 89 
exceeding 1 g/min will enhance exogenous carbohydrate availability when 90 
compared to the ingestion of an isoenergetic amount of glucose or glucose 91 
polymers. Moreover, since fructose appears to be preferentially directed to 92 
liver glycogen storage (relative to glucose) (32), sucrose may further prevent 93 
liver glycogen depletion during exercise. 94 
 95 
The present study aimed to investigate the effect of high rates of glucose and 96 
sucrose ingestion on net changes in liver and muscle glycogen contents and 97 
intramyocellular lipid concentrations using magnetic resonance spectroscopy 98 
(MRS). We hypothesized that high-rates of carbohydrate ingestion would 99 
spare liver glycogen during prolonged exercise, and that sucrose ingestion 100 
would better maintain liver glycogen relative to glucose ingestion.   101 
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Methods 102 
 103 
Study design 104 
Participants completed preliminary testing prior to 2 main trials, during which 105 
subjects either ingested glucose (GLU) or sucrose (SUC) in a randomized, 106 
double-blind, crossover design separated by 7-14 d. Trials were conducted at 107 
the Newcastle Magnetic Resonance Centre (Newcastle-upon-Tyne, UK) in 108 
accordance with the Second Declaration of Helsinki, and following approval 109 
from the Northumbria University Faculty of Health and Life Sciences Ethics 110 
Committee. Randomization was performed using online statistical software 111 
(http://www.randomizer.org/). Blinding and preparation of the test-drinks was 112 
performed by an assistant who was not involved in the exercise tests.  113 
In addition to the two main trials, four participants completed an additional 114 
control trial (CON) as a reference to establish the change in liver glycogen 115 
concentration without carbohydrate ingestion. This was identical to the SUC 116 
and GLU trials, with the exception that only water was ingested during 117 
exercise (identical volume to GLU and SUC trials), and blood sampling was 118 
not performed. 119 
 120 
Participants 121 
Fifteen trained cyclists were recruited for the study. Inclusion criteria included 122 
healthy, endurance trained, male cyclists; V̇O2peak ≥50 mL/min/kg/. Exclusion 123 
criteria included the use of medication that could influence substrate 124 
metabolism, smokers and any known metabolic disorders. One participant 125 
was unable to complete the full 3 h cycling protocol due to nausea on the GLU 126 
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trial and was therefore excluded from the analysis. Consequently, 14 127 
participants completed the two main trials. 128 
 129 
Preliminary testing 130 
An incremental cycling test was performed on an electromagnetically braked 131 
cycle ergometer (Velotron, RacerMate Inc., Seattle, WA, USA) to determine 132 
peak power output (Wpeak) and peak oxygen uptake (V̇O2peak). Following a 5-133 
min warm-up at 100 W, the workload began at 150 W and was increased by 134 
50 W every 2.5 min to voluntary exhaustion (23). Expired gas was sampled 135 
continuously to determine oxygen uptake (Oxycon gas analyser, CareFusion 136 
corporation, San Diego, CA, USA). 137 
 138 
Main trials 139 
Participants arrived at Newcastle Magnetic Resonance Centre at 0700-0800 h 140 
following a 12 h fast. Strenuous exercise was prohibited for 24 h prior to trials, 141 
and participants were asked to record and replicate dietary intake for 24 h 142 
prior to trials. The final meal consumed on the evening before the main trials 143 
was provided by the investigators to participants to standardize the 144 
macronutrient intake across participants for this meal (25 g protein, 51 g 145 
carbohydrate and 32 g fat; 2479 kJ; 592 kcal). 146 
 147 
MRS was used to determine liver and muscle glycogen and intramyocellular 148 
lipid concentrations prior to and following 3 h of cycling. Following a 5 min 149 
warm-up at 100 W, power output was increased to 50% Wpeak for the 150 
remainder of the 3 h. Immediately prior to exercise, participants were provided 151 
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with 600 mL (86.4 g carbohydrate) of the test-drink, and then a further 150 mL 152 
(21.6 g carbohydrate) every 15 min during exercise. Four of the 14 cyclists did 153 
not manage to consume all of the carbohydrate on their first trial (which was a 154 
GLU trial for two participants, and a SUC trial for the other two participants) 155 
and therefore their carbohydrate intake was replicated for their second trial 156 
(the carbohydrate intakes for these four cyclists therefore ranged from 238-157 
281 g, mean ± SD: 292 ± 101 g, compared to the 324 g prescribed). This lead 158 
to an average rate of carbohydrate intake for the entire group of 1.7 ± 0.2 159 
g/min and 1.7 ± 0.2 g/min (102 ± 12 g/h and 102 ± 12 g/h) during GLU and 160 
SUC trials, respectively (P > 0.05; Table 1). 161 
 162 
Carbohydrate drinks 163 
Carbohydrate drinks were prepared by mixing 108 g of carbohydrate with 750 164 
mL of water in an opaque bottle. This was replicated two more times to 165 
produce 3 bottles, each with 750 ml of a 7% carbohydrate solution; 324 g of 166 
carbohydrate in total. Both sources of carbohydrate were from plants that use 167 
C3 carbon fixation to minimize differences in the natural abundance of 13C 168 
(33). Accordingly, the glucose drink was produced with dextrose monohydrate 169 
obtained from wheat (Roquette, France) and the sucrose drink was produced 170 
with granulated sugar beet (AB Sugar, UK). 171 
 172 
Blood sampling and analysis 173 
Prior to exercise, an intravenous catheter was inserted into an antecubital 174 
vein for regular sampling. Blood samples were obtained prior to the exercise 175 
bout, and every 30 min during exercise. Briefly, 10 mL of blood was collected 176 
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in EDTA-vacutainers and immediately centrifuged at 2000 g for 10 min at 4°C. 177 
Plasma was then aliquoted and stored at -80°C for subsequent determination 178 
of insulin (IBL International, Hamburg, Germany) and non-esterified fatty acid 179 
(NEFA) concentrations (WAKO Diagnostics, Richmond, VA) in duplicate 180 
(intra- and inter-assay coefficients of variation all <10%). An additional 20 μL 181 
of whole blood was collected in a capillary tube and was used to determine 182 
glucose and lactate concentrations immediately (Biosen C_line, EKF 183 
Diagnostics, Magdeberg, Germany). 184 
 185 
Expired gas analysis 186 
Expired breath samples were taken every 30 min throughout exercise using 187 
the Douglas bag technique (9) accounting for variance in ambient oxygen and 188 
carbon dioxide concentrations (1). A mouthpiece connected to a two-way, 189 
non-rebreathing valve (model 2730, Hans Rudolph, Kansas City, Missouri), 190 
was used to collect gas samples (60 s sample after a 60 s stabilization 191 
phase), analysed for concentrations of oxygen and carbon dioxide using a 192 
paramagnetic and infrared transducers, respectively (Servomex 5200S, 193 
Crowborough, East Sussex, UK). Sensors were turned on 60 min prior to a 194 
two-point calibration (zero: 100% nitrogen; span: 20% oxygen and 8% carbon 195 
dioxide) using accuracy certified gas standards (BOC Industrial Gases, Linde 196 
AG, Munich, Germany). 197 
 198 
Ambient temperature, humidity and barometric pressure using a Fortin 199 
barometer (F.D. and company, Watford, UK) were recorded, and expired gas 200 
samples were corrected to standard temperature and pressure (dry). Volume 201 
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and temperature of expired gas samples were determined using a dry gas 202 
meter (Harvard Apparatus, Edenbridge, Kent, UK) and thermistor (model 810-203 
080, ETI, Worthing, UK), respectively, during gas evacuation. Calibration of 204 
the dry gas meter was performed regularly with a 3-L syringe (Series 5530, 205 
Hans-Rudolph Inc, Kansas City, Missouri, USA). 206 
 207 
Subjective ratings 208 
Ratings of gut discomfort were assessed every 30 min during exercise using a 209 
5-point scale, where 1 was anchored at “no discomfort’ and 5 at “maximum 210 
discomfort”. Ratings of perceived exertion (RPE) were assessed using the 211 
Borg scale (2). 212 
 213 
Measurement of muscle and liver glycogen 214 
Tissue glycogen concentration was determined from the magnitude of the 215 
natural abundance signal from the C-1 carbon of glycogen at a frequency of 216 
100.3 ppm. A Philips 3 Tesla Achieva scanner (Philips Healthcare, Best, The 217 
Netherlands) was used with a 6 cm diameter 13C surface coil with integral 1H 218 
decoupling surface coil (PulseTeq, Worton under Edge, UK) to measure 219 
muscle glycogen concentration and an in-house built 12 cm 13C/1H surface 220 
coil used to measure liver glycogen concentration.  221 
 222 
For muscle glycogen measurements, the surface coil was placed over the 223 
widest part of the Vastus lateralis and the leg was held in position with fabric 224 
straps to prevent movement. Pulse power was calibrated to a nominal value 225 
of 80° by observing the power dependent variation in signal from a fiducial 226 
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marker located in the coil housing, containing a sample exhibiting 13C signal 227 
with short T1 (213 mM [2-13C]-acetone and 25 mM GdCl3 in water). Automated 228 
shimming was carried out to ensure that the magnetic field within the scanner 229 
was uniform over the active volume of the 13C coil. The 13C spectra were 230 
acquired over 15 min using a non-localized 1H decoupled 13C pulse-acquire 231 
sequence (TR 120 ms, spectral width 8 kHz, 7000 averages, WALTZ 232 
decoupling). 1H decoupling was applied for 60% of the 13C signal acquisition 233 
to allow a relatively fast TR of 120 ms to be used within the Specific 234 
Absorption Rate safety limitations. 235 
 236 
For liver glycogen measurements the 13C/1H surface coil was placed over the 237 
right lobe of the liver. Spectra were acquired over 15 min using non-localized 238 
1H decoupled 13C pulse acquisition sequences (TR 300 ms, spectral width 8 239 
kHz, 2504 averages, WALTZ decoupling, nominal 13C tip angle of 80°). Scout 240 
images were obtained at the start of each study to confirm optimal coil 241 
position relative to the liver.  242 
 243 
Tissue glycogen concentrations were calculated from the amplitude of the C1-244 
glycogen 13C signal using Java Based Magnetic Resonance User Interface 245 
(jMRUI) version 3.0 and the AMARES algorithm [7] as described in detail 246 
previously (25, 26, 28, 37). 247 
  248 
Measurement of intramyocellular lipid 249 
Intramyocellular lipid content was determined routinely, as described in more 250 
detail previously (37). In short, a 12 cm 1H transmitter/receiver coil was used 251 
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to obtain 1H spectra to measure intramyocellular lipid (IMCL) content in the 252 
widest part of the gastrocnemius. The PRESS (Point Resolved Spectroscopy) 253 
(4) sequence was used to acquire 1H spectra from a 2×2×2 cm voxel, using 254 
an echo time of 25 ms, spectral resolution of 1 Hz and repetition time of 5000 255 
ms with 32 acquisitions. Spectra were analyzed with JMRUI version 3.0 using 256 
the least square fitting AMARES algorithm (4, 31). The inter-observer bias 257 
was 0.09 mmol/L with a 95% limit of agreement of 0.8 mmol/L (P > 0.05).  258 
 259 
Calculations and statistical analysis 260 
Due to the lack of data regarding exercise-induced changes in liver glycogen 261 
concentrations with carbohydrate feeding, a sample size estimation was 262 
based on data from exogenous carbohydrate oxidation rates (as a surrogate 263 
for carbohydrate availability). Sucrose increases exogenous carbohydrate 264 
oxidation during cycling by ~30% (18). Using this figure, along with the 7% 265 
intra-individual coefficient of variation of hepatic glycogen content measured 266 
by 13C MRS (34), the study was designed to provide statistical power above 267 
90% with an alpha level of 0.05 with a minimum sample size of n = 7 in a 268 
crossover design (10). 269 
 270 
Whole-body rates of carbohydrate and lipid utilization were estimated using 271 
the following equations assuming negligible protein oxidation (13, 22): 272 
 273 
Net lipid utilization (g/min) = (1.695 × V̇O2) - (1.701 × V̇CO2) 274 
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Net carbohydrate utilization (g/min) = (4.210 × V̇CO2) - (2.962 × V̇O2) 275 
 276 
Units of V̇O2 and V̇CO2 are L/min 277 
 278 
Unless otherwise stated, all data were expressed in the text as the mean ± 279 
standard deviation (SD) of the mean and the error bars presented in figures 280 
are 95% confidence intervals (CI). Data were checked for normal distribution 281 
and log-transformed if appropriate prior to statistical analysis. 282 
 283 
Liver and muscle glycogen, and IMCL concentrations from the four 284 
participants who completed the CON trial were assessed by two-way (trial x 285 
time) repeated measures ANOVA with trial (GLU vs SUC vs CON) and time 286 
(pre- vs post-exercise) as within-subject factors. Rates of substrate utilization 287 
were assessed by a one-way repeated measures (GLU vs SUC vs CON) 288 
ANOVA. No further inferential statistics were performed on CON data since 289 
this was only a subgroup of the total sample and was only used as a 290 
reference for the change in liver glycogen concentration with 3 h of exercise in 291 
the absence of carbohydrate ingestion. Accordingly, all other comparisons 292 
were made between GLU and SUC only. 293 
 294 
Blood, plasma and respiratory variables and subjective ratings were assessed 295 
by two-way (trial x time) repeated measures ANOVA with trial (GLU vs SUC) 296 
and time (all time points during exercise) as within-subject factors. Liver and 297 
muscle glycogen and intramyocellular lipid concentrations were also assessed 298 
by two-way (trial x time) repeated measures ANOVA with trial (GLU vs SUC) 299 
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and time (pre- vs post-exercise) as within-subject factors. Mean exercise 300 
responses in GLU and SUC trials (carbohydrate intake, heart rate, fluid intake 301 
and power output) were assessed by paired t-tests. All P values are corrected 302 
for multiple comparisons (Holm-Sidak). A P value of ≤ 0.05 was used to 303 
determine statistical significance. All data were analyzed using Prism v5 304 
(GraphPad Software, San Diego, CA).  305 
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Results 306 
 307 
Participants 308 
Participants’ characteristics are provided in Table 2. No differences were 309 
observed for age, body mass, height, V̇O2 peak, Wpeak, body mass index, 310 
systolic or diastolic blood pressure between participants who completed the 311 
main trials (GLU and SUC) and the subgroup of participants who also 312 
completed the additional CON trial.  313 
 314 
Subjective ratings 315 
RPE increased during exercise (time effect, P < 0.001), but to less of an 316 
extent during SUC when compared to GLU (interaction effect, P < 0.05; 317 
Figure 1A), becoming significantly different between trials from 150 min 318 
onwards (P < 0.05). Similarly, ratings of gut discomfort increased throughout 319 
exercise (time effect, P < 0.001) but to less of an extent during SUC when 320 
compared to GLU (interaction effect, P < 0.01), becoming significantly 321 
different at 180 min (Figure 1B, P < 0.05). 322 
 323 
Respiratory data and whole-body substrate utilization 324 
V̇O2  and V̇CO2  remained stable during exercise (time effect, P > 0.05 for 325 
both) and were not different between GLU and SUC (both P > 0.05). 326 
Respiratory exchange ratio (RER) was higher with SUC vs GLU (trial effect, P 327 
< 05) for time points 90 min onwards (interaction effect, P < 0.05; Figure 2C). 328 
Whole-body carbohydrate utilization rates were higher during SUC (2.03 ± 329 
0.43 g/min) when compared with GLU (1.66 ± 0.36 g/min; P < 0.05), at the 330 
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expense of fat oxidation rates (SUC: 0.35 ± 0.15 vs GLU: 0.48 ± 0.12 g/min; P 331 
< 0.05), resulting in energy expenditure rates that did not differ between trials 332 
(SUC: 8.8 ± 1.2 vs GLU: 8.6 ± 0.9 MJ; P > 0.05; Figure 3A). In the subgroup 333 
who also completed the CON trial (n = 4), whole-body fat oxidation rates were 334 
lower during both GLU (0.42 ± 0.10 g/min) and SUC (0.33 ± 0.11 g/min), 335 
compared to CON (0.64 ± 0.19 g.min; P < 0.05), whilst carbohydrate oxidation 336 
rates (SUC: 2.04 ± 0.40 vs GLU: 1.79 ± 0.43 vs CON: 1.20 ± 0.44 MJ) did not 337 
significantly differ between trials (P > 0.05). Accordingly, energy expenditure 338 
(SUC: 8.7 ± 0.6 vs GLU: 8.6 ± 0.8 vs CON: 8.4 ± 0.4 MJ) also did not differ 339 
between trials (P > 0.05; Figure 3B). 340 
 341 
Circulating metabolite and insulin concentrations 342 
Blood glucose and plasma insulin concentrations were not significantly 343 
different between trials (trial effect, P > 0.05; interaction effect, P > 0.05 for 344 
both variables; Figure 4A). In contrast, blood lactate concentrations were 345 
higher with SUC vs GLU (trial effect, P < 0.01), rising at the onset of exercise 346 
(time effect, P < 0.001) to a greater extent in SUC vs GLU until 120 min 347 
(interaction effect, P < 0.01; Figure 4B). Plasma NEFA concentrations fell 348 
from ~0.5 mmol/L to ~0.2 mmol/L during the first hour of exercise before rising 349 
again (time effect, P < 0.001), the latter of which occurred to a greater degree 350 
in GLU compared to SUC (interaction effect, P < 0.01; Figure 4D). 351 
 352 
Muscle and liver glycogen concentration 353 
Muscle and liver glycogen concentrations are displayed in Figures 5A, 5B, 354 
5C and 5D. Pre-exercise, no differences were observed in liver and muscle 355 
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glycogen concentrations between trials P > 0.05 for both variables). The day-356 
to-day coefficients of variation for pre-exercise liver and muscle glycogen 357 
concentrations were 12% and 20%, respectively. The between subject 358 
coefficient of variation for pre-exercise liver and muscle glycogen were 54% 359 
and 41%, respectively. In the subgroup who also completed the CON trial (n = 360 
4), liver glycogen concentrations declined during exercise in CON, but not 361 
when either glucose or sucrose were ingested (interaction effect, P < 0.05; 362 
Figure 5B). In contrast to the liver, muscle glycogen concentrations declined 363 
during exercise regardless of trial (trial effect, P > 0.05; time effect, P < 0.01; 364 
interaction effect, P > 0.05; Figure 5D).  365 
 366 
Post-exercise liver glycogen concentrations did not differ from pre-exercise 367 
values when either glucose or sucrose were ingested (time effect, P > 0.05; 368 
interaction effect, P > 0.05). The change in liver glycogen concentrations from 369 
pre- to post-exercise was positive with glucose (20 ± 55 mmol/L) and sucrose 370 
(27 ± 58 mmol/L; P > 0.05 GLU vs SUC) ingestion, but negative in the CON 371 
treatment (-171 ± 73 mmol/L).  372 
 373 
Muscle glycogen concentrations were reduced following exercise (time effect, 374 
P < 0.001). The changes in muscle glycogen concentrations did not differ 375 
between trials (trial effect, P > 0.05; interaction effect, P > 0.05; Figures 5C 376 
and 4D). The pre- to post-exercise changes in muscle glycogen concentration 377 
did not differ between GLU (-40 ± 37 mmol/L) and SUC (-47 ± 36; P > 0.05). 378 
 379 
Intramyocellular lipid concentration 380 
 Page 18 of 31 
No differences were observed in pre-exercise IMCL concentration (P > 0.05) 381 
between trials. The day-to-day coefficient of variation for pre-exercise IMCL 382 
concentration was 21%. The between-subject coefficient of variation for pre-383 
exercise IMCL concentration was 47%. In the full sample (n = 14) exercise 384 
decreased IMCL concentrations (time effect P < 0.01) to a similar extent in 385 
both trials (trial effect, P > 0.05; interaction effect, P > 0.05; Figure 5E). The 386 
pre- to post-exercise changes in IMCL concentration did not differ between 387 
GLU (-1.5 ± 6.0 μmol/g) and SUC (-1.6 ± 6.4 μmol/g; P > 0.05). 388 
 389 
In the subgroup who completed the CON trial (n = 4), post-exercise IMCL 390 
concentrations were not significantly different to pre-exercise values (time 391 
effect, P > 0.05), and the responses were not significantly different between 392 
trials (trial effect, P > 0.05; interaction effect, P > 0.05; Figure 5F).  393 
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Discussion 394 
In the present study we provide novel data demonstrating that carbohydrate 395 
ingestion during endurance type exercise can prevent liver glycogen 396 
depletion, and that this effect is independent of the type of carbohydrate 397 
(glucose or sucrose) ingested. In contrast, neither glucose nor sucrose 398 
ingestion at 1.7 g/min (102 g/h) could attenuate the decline in muscle 399 
glycogen following exercise. Sucrose ingestion increased whole-body 400 
carbohydrate utilization when compared with glucose ingestion. 401 
 402 
Muscle glycogen and plasma glucose are the main fuel sources during 403 
prolonged, moderate-intensity endurance type exercise (41). Plasma glucose 404 
is maintained during exercise by glycogenolysis and gluconeogenesis, 405 
primarily from the liver. Accordingly, continuous exercise lasting more than 60 406 
min substantially depletes liver glycogen concentrations (37). Given that liver 407 
glycogen strongly associates with endurance capacity (6), maintaining liver 408 
glycogen concentrations is likely to benefit endurance performance. Previous 409 
research using glucose tracers has indicated that high rates of glucose 410 
ingestion can suppress endogenous glucose appearance (21), implying that 411 
carbohydrate ingestion during exercise may attenuate exercise induced liver 412 
glycogen depletion. Here we present the first quantitative evidence of liver 413 
glycogen maintenance following carbohydrate ingestion during exercise. We 414 
found that 3 h of cycling, in the absence of carbohydrate ingestion reduces 415 
liver glycogen concentrations by ~49%, which is consistent with previous 416 
findings (37). When ingesting ~1.7 g/min (~102 g/h) glucose or sucrose, liver 417 
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glycogen concentrations are not lowered during prolonged exercise (Figures 418 
5A and 5B). 419 
 420 
Liver glycogen concentrations displayed a relatively high variability between 421 
subjects (coefficient of variation: 54%), compared to the day-to-day variability 422 
within subjects (coefficient of variation: 12%). This provides an explanation for 423 
the relatively higher baseline liver glycogen concentrations in the subgroup 424 
that completed the CON trial (n = 4; Figure 5B) compared to the entire sample 425 
(n = 14; Figure 5A). 426 
 427 
Carbohydrate ingestion during exercise increases exogenous carbohydrate 428 
oxidation and has been shown to spare net muscle glycogen utilization under 429 
some conditions (36), although not typically during the latter stages of more 430 
prolonged (> 1 h), cycling exercise. These responses are thought to contribute 431 
to the performance benefits of carbohydrate ingestion during prolonged 432 
exercise (7). The present data demonstrate that neither the ingestion of 433 
glucose nor sucrose are able to attenuate net muscle glycogen utilization 434 
during prolonged moderate-intensity cycling, even when large quantities of 435 
multiple transportable carbohydrate (~1.7 g/min; 102 g/h) are ingested that 436 
augment exogenous carbohydrate availability. In contrast, whole body 437 
carbohydrate utilization rates were higher with sucrose vs glucose ingestion, 438 
with a concomitant reduction in fat use. Data from the subgroup also 439 
demonstrate that both glucose and sucrose ingestion suppress fat utilization 440 
relative to CON, although the numerical differences in carbohydrate utilization 441 
rates did not reach statistical significance with the subgroup (n = 4; P = 0.07). 442 
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At rest, fructose is preferentially stored as liver glycogen rather than muscle 443 
glycogen. This has led some to speculate that sucrose, when compared with 444 
glucose ingestion may be particularly effective at maintaining or increasing 445 
liver glycogen during exercise. In the present study, sucrose ingestion did not 446 
preserve liver glycogen concentrations to any greater extent than glucose 447 
ingestion. In line with previous observations of substantial declines in 448 
endogenous glucose production during exercise when glucose was ingested 449 
(21), our data seem to suggest that liver glycogen contents are maintained 450 
during exercise when ingesting large amounts (~1.7 g/min; ~102 g/h) of 451 
glucose or sucrose. The surplus carbohydrates are shunted towards oxidation 452 
rather than storage, at the expense of lipid oxidation. 453 
  454 
The increase in whole-body carbohydrate utilization following sucrose vs 455 
glucose ingestion seems to confirm that sucrose ingestion increases 456 
exogenous carbohydrate availability and carbohydrate flux. This shift in 457 
metabolism is likely due to a number of coordinated factors, including the 458 
higher lactate concentrations observed following sucrose ingestion. Higher 459 
circulating lactate concentrations are very likely due to the fructose 460 
component of sucrose, the majority of which is converted to lactate and 461 
glucose upon bypassing the liver. Glucose-fructose co-ingestion during 462 
exercise has been shown to increase plasma lactate and glucose turnover 463 
and oxidation (24), with a minimal amount of fructose being directly oxidized 464 
(24). The greater whole-body carbohydrate utilization rate following sucrose 465 
ingestion is therefore likely attributed to a combination of (greater) plasma 466 
lactate, glucose and (to a lesser extent) fructose oxidation rates. Lactate also 467 
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inhibits adipocyte lipolysis via the G-protein coupled receptor GPR81 (27). 468 
This is likely one of the factors responsible for the lower plasma NEFA 469 
concentrations following sucrose versus glucose ingestion in the presence of 470 
similar insulinemia. As there were no differences in muscle lipid content 471 
changes between treatments, the greater fat use in the glucose compared 472 
with the sucrose trial is likely entirely attributed to greater uptake and 473 
oxidation of plasma derived NEFA.  474 
 475 
Lactate formation is associated with hydrogen ion production, which may 476 
displace CO2 from bicarbonate stores with consequent implications for 477 
estimates of V̇CO2 , RER and substrate utilization (13). The ~0.5 mmol/L 478 
increase in lactate concentration following SUC vs GLU however, would have 479 
a negligible (<0.07 mL/min) effect on CO2 displacement (13). Therefore, 480 
values obtained from expiratory gas samples are likely to be a valid 481 
representation of net substrate utilization. 482 
 483 
We observed a lower RPE towards the end of exercise following sucrose 484 
compared with glucose ingestion. This is in spite of the higher lactate 485 
concentrations following ingestion of sucrose compared to glucose, offering 486 
additional evidence of the disassociation between lactate concentrations and 487 
RPE (29). Exogenous carbohydrate oxidation rates have been shown to 488 
correlate with exercise performance during prolonged, moderate-to-high 489 
intensity exercise (35). Therefore, the lower RPE following sucrose versus 490 
glucose ingestion may be attributed to the greater exogenous carbohydrate 491 
uptake and subsequent oxidation rates when co-ingesting fructose (17, 19). 492 
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The lower RPE may of course also be directly attributed to the lesser 493 
occurrence of gastrointestinal discomfort when ingesting large amounts of 494 
multiple transportable carbohydrates versus glucose only (Figure 1).  495 
 496 
In conclusion, ingestion of large amounts [~1.7 g/min (~102 g/h), relative to 497 
the ~1.5 g/min (90 g/h) recommended for exercise lasting >2.5 h] of glucose 498 
or sucrose during prolonged endurance type exercise prevent the exercise-499 
induced decline in liver glycogen content without modulating muscle glycogen 500 
depletion.  501 
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FIGURE LEGENDS 650 
Figure 1 Ratings of perceived exertion (A) and gut discomfort (B) during 3 h 651 
of cycling with ingestion of glucose or sucrose in trained cyclists (n = 14). Data 652 
are expressed as means ± 95% CI. * P < 0.05, significantly different between 653 
GLU and SUC. GLU, glucose; SUC, sucrose. 654 
 655 
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Figure 2 VO2 (A), VCO2 (B) and respiratory exchange ratio (C) during 3 h of 656 
cycling with ingestion of glucose or sucrose in trained cyclists (n = 14). Data 657 
are expressed as means ± 95% CI. * P < 0.05, significantly different between 658 
GLU and SUC. GLU, glucose; SUC, sucrose; VCO2, rate of carbon dioxide 659 
production; VO2, rate of oxygen consumption. 660 
   661 
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Figure 3 Substrate utilization during 3 h of cycling with ingestion of glucose or 662 
sucrose in trained cyclists (A; n = 14) and in the subgroup of trained cyclists 663 
(B; n = 4). Data are expressed as means ± 95% CI. * P < 0.05, significantly 664 
different from CON. CHO, carbohydrate; GLU, glucose; SUC, sucrose; CON, 665 
water control. 666 
 667 
  668 
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Figure 4 Blood glucose (A) and lactate (B), and plasma insulin (C) and NEFA 669 
(D) concentrations during 3 h of cycling with ingestion of glucose or sucrose in 670 
trained cyclists (n = 14). Data are expressed as means ± 95% CI. * P < 0.05, 671 
significantly different between GLU and SUC. GLU, glucose; NEFA, non-672 
esterified fatty acid; SUC, sucrose. 673 
 674 
  675 
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Figure 5 Liver glycogen (A), muscle glycogen (C) and intramyocellular lipid 676 
(E) concentrations prior to (Pre) and immediately following (Post) 3 h of 677 
cycling with ingestion of glucose or sucrose in the full sample of trained 678 
cyclists (n = 14), and in the subgroup of trained cyclists (B, D and F; n = 4). 679 
Data are expressed as means ± 95% CI. * P < 0.05, significantly different 680 
when compared with pre-exercise values. GLU, glucose; SUC, sucrose; CON, 681 
water control.682 
  683 
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Table 1 Carbohydrate intake and physiological variables of trained cyclists 684 
during 3 h of cycling with ingestion of glucose, sucrose or water.  685 
 GLU  
(n = 14) 
SUC 
(n = 14) 
CON 
(n = 4) 
Carbohydrate intake (g/min) 1.7 ± 0.2 1.7 ± 0.2 0 ± 0 
Fluid intake (L) 2.1 ± 0.2 2.2 ± 0.2 2.3 ± 0.0 
Power output (W) 165 ± 17 165 ± 17 158 ± 7 
Mean heart rate (beats/min) 145 ± 14 146 ± 12 122 ± 8 
Data are expressed as means ± SEM. GLU, glucose; SUC, sucrose; CON, 686 
water control. 687 
 688 
 689 
 690 
 691 
 692 
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Table 2 Characteristics of trained cyclists who completed GLU, SUC and 694 
CON trials. 695 
 696 
 697 
 698 
 699 
 700 
 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
Data are expressed as means ± SD. GLU, glucose; SUC, sucrose; V̇O2peak, 709 
peak oxygen uptake; CON, water control; Wpeak, peak power output. 710 
 711 
 GLU and SUC 
(n = 14) 
CON 
(n = 4) 
Age (y) 25 ± 5 26 ± 6 
Body mass (kg) 73.1 ± 9.3 75.3 ± 10.7 
Height (m) 1.78 ± 0.08 1.75 ± 0.09 
V̇O2peak (mL/min/kg) 58 ± 5 60± 7 
Wpeak (W) 330 ± 35 316 ± 27 
BMI (kg/m2) 23.0 ± 1.9 24.5 ± 1.8 
Systolic blood pressure 
(mmHg) 
133 ± 11 129 ± 6 
Diastolic blood pressure 
(mmHg) 
74 ± 8 71 ± 8 
